Amicus Therapeutics Inc
NASDAQ:FOLD

Watchlist Manager
Amicus Therapeutics Inc Logo
Amicus Therapeutics Inc
NASDAQ:FOLD
Watchlist
Price: 11.42 USD -1.38% Market Closed
Market Cap: 3.4B USD
Have any thoughts about
Amicus Therapeutics Inc?
Write Note

Amicus Therapeutics Inc
Net Issuance of Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amicus Therapeutics Inc
Net Issuance of Debt Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Debt CAGR 3Y CAGR 5Y CAGR 10Y
Amicus Therapeutics Inc
NASDAQ:FOLD
Net Issuance of Debt
-$21m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Issuance of Debt
$9.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Net Issuance of Debt
-$2.1B
CAGR 3-Years
N/A
CAGR 5-Years
7%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Net Issuance of Debt
$1.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-18%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Issuance of Debt
-$48.4m
CAGR 3-Years
-25%
CAGR 5-Years
-13%
CAGR 10-Years
2%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Issuance of Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Amicus Therapeutics Inc's Net Issuance of Debt?
Net Issuance of Debt
-21m USD

Based on the financial report for Jun 30, 2024, Amicus Therapeutics Inc's Net Issuance of Debt amounts to -21m USD.

What is Amicus Therapeutics Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 1Y
-7 137%

Over the last year, the Net Issuance of Debt growth was -7 137%.

Back to Top